Ascentage Pharma Group International (AAPG) Receivables - Net (2023 - 2025)
Historic Receivables - Net for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $10.9 million.
- Ascentage Pharma Group International's Receivables - Net changed N/A to $10.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $10.9 million, marking a year-over-year change of. This contributed to the annual value of $11.4 million for FY2024, which is 4482.71% down from last year.
- Ascentage Pharma Group International's Receivables - Net amounted to $10.9 million in Q2 2025.
- Over the past 5 years, Ascentage Pharma Group International's Receivables - Net peaked at $20.3 million during Q4 2023, and registered a low of $10.9 million during Q2 2025.
- In the last 3 years, Ascentage Pharma Group International's Receivables - Net had a median value of $11.6 million in 2024 and averaged $14.3 million.
- Examining YoY changes over the last 5 years, Ascentage Pharma Group International's Receivables - Net showed a top increase of 4287.63% in 2024 and a maximum decrease of 4287.63% in 2024.
- Quarter analysis of 3 years shows Ascentage Pharma Group International's Receivables - Net stood at $20.3 million in 2023, then crashed by 42.88% to $11.6 million in 2024, then dropped by 5.49% to $10.9 million in 2025.
- Its Receivables - Net stands at $10.9 million for Q2 2025, versus $11.6 million for Q4 2024 and $20.3 million for Q4 2023.